Matthew J. Zimpfer - 10 Feb 2026 Form 4 Insider Report for CNO Financial Group, Inc. (CNO)

Role
General Counsel
Signature
Heidi M. Krings, Attorney-in-Fact
Issuer symbol
CNO
Transactions as of
10 Feb 2026
Net transactions value
+$85,535
Form type
4
Filing time
12 Feb 2026, 17:28:43 UTC
Previous filing
18 Nov 2025
Next filing
18 Feb 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Zimpfer Matthew J. General Counsel C/O CNO FINANCIAL GROUP, INC., 11299 ILLINOIS STREET, SUITE 200, CARMEL Heidi M. Krings, Attorney-in-Fact 12 Feb 2026 0001438233

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CNO Common Stock Award $1,092,781 +25,384 +9.2% $43.05 301,300 10 Feb 2026 Direct F1
transaction CNO Common Stock Tax liability $329,892 -7,663 -2.5% $43.05 293,637 10 Feb 2026 Direct F2
transaction CNO Restricted Stock Units Award $0 +14,300 +4.9% $0.000000 307,937 10 Feb 2026 Direct F3, F4
transaction CNO Common Stock Options Exercise $652,228 +30,970 +10% $21.06 338,907 12 Feb 2026 Direct
transaction CNO Common Stock Sale $1,329,582 -30,970 -9.1% $42.93 307,937 12 Feb 2026 Direct F5, F6

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CNO Employee Stock Option (Right to Buy) Options Exercise $0 -30,970 -100% $0.000000 0 12 Feb 2026 Common Stock 30,970 $21.06 Direct F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 Shares were acquired upon the vesting of performance share units for the 2023-2025 performance period, based on the issuer's (i) 2023 operating return on equity, (ii) 2023 operating earnings per share and (iii) three-year relative total shareholder return for 2023-2025.
F2 Shares were surrendered to the issuer to cover the required tax withholding on the vested performance share units.
F3 Restricted stock units convert into common stock on a one-for-one basis.
F4 The restricted stock units vest in three equal annual installments beginning March 25, 2027, subject to continued employment with the issuer or one of its subsidiaries.
F5 Shares sold pursuant to a Rule 10b5-1 trading plan adopted on June 9, 2025.
F6 Reflects the weighted average sale price. Shares were sold at prices ranging from $42.31 per share to $43.75 per share. Reporting person will provide full information regarding the number of shares sold at each separate price upon request by the SEC staff, the issuer or any security holder of the issuer.
F7 One-half of the stock options vested on February 23, 2019, and one-half vested on February 23, 2020.